Effect of pregnancy on topiramate pharmacokinetics in rabbits

Xenobiotica

Volumn 41, Issue 5, 2011, Pages 416-421

  Matar, Kamal M ^a   Marafie, Najlaa A ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Antiepileptics; pharmacokinetics; pregnancy; rabbits; topiramate

Indexed keywords

TOPIRAMATE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG HALF LIFE; FEMALE; GESTATION PERIOD; NONHUMAN; PREGNANCY; RABBIT; TANDEM MASS SPECTROMETRY; TIME TO MAXIMUM PLASMA CONCENTRATION;

ANIMALS; FEMALE; FRUCTOSE; PREGNANCY; RABBITS; TIME FACTORS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 79954554195     PISSN: 00498254     EISSN: 13665928     Source Type: Journal    
DOI: 10.3109/00498254.2010.549969     Document Type: Article

References (29)

1. Anderson GD. (2005). Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 44:989-1008. (Pubitemid 41356388)
2. Battino D, Tomson T. (2007). Management of epilepsy during pregnancy. Drugs 67:2727-2746. (Pubitemid 350224382)
3. Brodtkorb E, Reimers A. (2008). Seizure control and pharmacokinetics of antiepileptic drugs in pregnant women with epilepsy. Seizure 17:160-165.
4. Caldwell GW, Wu WN, Masucci JA, McKown LA, Gauthier D, Jones WJ, Leo GC, Maryanoff BE. (2005). Metabolism and excretion of the antiepileptic/antimigraine drug, topiramate in animals and humans. Eur J Drug Metab Pharmacokinet 30:151-164. (Pubitemid 41499256)
5. Chamberlain A, White S, Bawdon R, Thomas S, Larsen B. (1993). Pharmacokinetics of ampicillin and sulbactam in pregnancy. Am J Obstet Gynecol 168:667-673. (Pubitemid 23069134)
6. Davison JM, Dunlop W, Ezimokhai M. (1980). 24-hour creatinine clearance during the third trimester of normal pregnancy. Br J Obstet Gynaecol 87:106-109. (Pubitemid 10156189)
7. Garnett W. (2000). Clinical pharmacology of topiramate: a review. Epilepsia 41(Suppl 1):S61-S65. (Pubitemid 30202344)
8. Gidal BE, Lensmeyer GL. (1999). Therapeutic monitoring of topiramate: evaluation of the saturable distribution between erythrocytes and plasma of whole blood using an optimized high-pressure liquid chromatography method. Ther Drug Monit 21:567-576. (Pubitemid 29468327)
9. Heikkila A, Erkkola R. (1991). Pharmacokinetics of piperacillin during pregnancy. J Antimicrob Chemother 28:419-423.
10. Hunt S, Russell A, Smithson WH, Parsons L, Robertson I, Waddell R, Irwin B, Morrison PJ, Morrow J, Craig J; UK Epilepsy and Pregnancy Register. (2008). Topiramate in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register. Neurology 71:272-276.
11. Kjellstrom S, Bruun A, Isaksson B, Eriksson T, Andreasson S, Ponjavic V. (2006). Retinal function and histopathology in rabbits treated with topiramate. Doc Ophthalmol 113:179-186. (Pubitemid 44835002)
12. Lander CM, Eadie MJ. (1991). Plasma antiepileptic drug concentrations during pregnancy. Epilepsia 32:257-266.
13. Langtry HD, Gillis JC, Davis R. (1997). Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy. Drugs 54:752-773. (Pubitemid 27480245)
14. Loebstein R, Lalkin A, Koren G. (1997). Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 33:328-343. (Pubitemid 27480937)
15. Lyseng-Williamson KA, Yang LP. (2007). Topiramate: a review of its use in the treatment of epilepsy. Drugs 67:2231-2256. (Pubitemid 47557096)
16. Matar KM. (2010). Therapeutic drug monitoring of topiramate by liquid chromatography-tandem mass spectrometry. Clin Chim Acta 411:729-734.
17. Michelucci R, Passarelli D, Riguzzi P, Volpi L, Tassinari C. (1998). The preclinical and therapeutic activity of the novel anticonvulsant topiramate. CNS Drug Rev 4:165-186. (Pubitemid 29090861)
18. Ohman I, Sabers A, de Flon P, Luef G, Tomson T. (2009). Pharmacokinetics of topiramate during pregnancy. Epilepsy Res 87:124-129.
19. Ohman I, Vitols S, Luef G, Soderfeldt B, Tomson T. (2002). Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations. Epilepsia 43:1157-1160. (Pubitemid 35176121)
20. Pennell PB. (2003). Antiepileptic drug pharmacokinetics during pregnancy and lactation. Neurology 61:S35-S42. (Pubitemid 37174463)
21. Philipson A, Stiernstedt G. (1982). Pharmacokinetics of cefuroxime in pregnancy. Am J Obstet Gynecol 142:823-828. (Pubitemid 12142940)
22. Sabers A, Tomson T. (2009). Managing antiepileptic drugs during pregnancy and lactation. Curr Opin Neurol 22:157-161.
23. Sachdeo RC, Sachdeo SK, Levy RH, Streeter AJ, Bishop FE, Kunze KL, Mather GG, Roskos LK, Shen DD, Thummel KE, Trager WF, Curtin CR, Doose DR, Gisclon LG, Bialer M. (2002). Topiramate and phenytoin pharmacokinetics during repetitive monotherapy and combination therapy to epileptic patients. Epilepsia 43:691-696. (Pubitemid 34774249)
24. Shank R, Gardocki J, Streeter A, Maryanoff B. (2000). An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 41(Suppl 1):S3-S9.
25. Tomson T. (2005). Gender aspects of pharmacokinetics of new and old AEDs: pregnancy and breast-feeding. Ther Drug Monit 27:718-721. (Pubitemid 44391722)
26. Tomson T, Battino D. (2007). Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium. Clin Pharmacokinet 46:209-219. (Pubitemid 46425647)
27. Westin AA, Nakken KO, Johannessen SI, Reimers A, Lillestolen KM, Brodtkorb E. (2009). Serum concentration/dose ratio of topiramate during pregnancy. Epilepsia 50:480-485.
28. Westin AA, Reimers A, Helde G, Nakken KO, Brodtkorb E. (2008). Serum concentration/dose ratio of levetiracetam before, during and after pregnancy. Seizure 17:192-198.
29. Wu W, Heebner J, Streeter A, Moyer M, Takacs A. (1994). Evaluation of the absorption, excretion, pharmacokinetics and metabolism of the anticonvulsant, topiramate in healthy men. Pharm Res 11(Suppl):S336.